Bendall Jennifer K, Rinze Ruth, Adlam David, Tatham Amy L, de Bono Joe, Wilson Natalie, Volpi Emanuela, Channon Keith M
Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, OX39DU, UK.
Circ Res. 2007 Apr 13;100(7):1016-25. doi: 10.1161/01.RES.0000263381.83835.7b. Epub 2007 Mar 15.
Vascular disease states are associated with endothelial dysfunction and increased production of reactive oxygen species (ROS) derived from vascular NADPH oxidases in both vascular smooth muscle cells (VSMCs) and endothelial cells. Recent evidence suggests an important role for VSMC NADPH oxidases in vascular ROS production. However, it is unclear whether increased NADPH oxidase activity in endothelial cells alone is sufficient to alter overall vascular ROS production and hemodynamics. We sought to address these questions using transgenic mice with endothelial-targeted overexpression of the catalytic subunit of NADPH oxidase, Nox2. Aortas of Nox2 transgenic (Nox2-Tg) mice had increased total Nox2 mRNA and protein levels compared with wild-type littermates. Both p22phox mRNA and protein levels were also significantly elevated in Nox2-Tg aortas. Aortic superoxide production was significantly increased in Nox2-Tg mice compared with wild-type, but this difference was abolished by endothelial removal. Superoxide dismutase inhibition increased superoxide release and levels of Mn superoxide dismutase protein were significantly elevated in aortas from Nox2-Tg mice compared with wild type. Increased ROS production from endothelial Nox2 overexpression led to increased endothelial nitric oxide synthase protein and extracellular signal-regulated kinase 1/2 phosphorylation in transgenic aortas. Basal blood pressure was similar, however the pressor responses to both acute and chronic angiotensin II administration were significantly increased in Nox2-Tg mice compared with wild type. These results demonstrate that endothelial-targeted Nox2 overexpression is sufficient to increase vascular NADPH oxidase activity, activate downstream signaling pathways, and potentiate the hemodynamic response to angiotensin II, despite compensatory increases in vascular antioxidant enzymes. Endothelial cell Nox2-containing NADPH oxidase plays an important functional role in vascular redox signaling.
血管疾病状态与内皮功能障碍以及血管平滑肌细胞(VSMC)和内皮细胞中源自血管NADPH氧化酶的活性氧(ROS)生成增加有关。最近的证据表明VSMC NADPH氧化酶在血管ROS生成中起重要作用。然而,尚不清楚仅内皮细胞中NADPH氧化酶活性增加是否足以改变整体血管ROS生成和血流动力学。我们试图通过对NADPH氧化酶催化亚基Nox2进行内皮靶向过表达的转基因小鼠来解决这些问题。与野生型同窝小鼠相比,Nox2转基因(Nox2-Tg)小鼠的主动脉中总Nox2 mRNA和蛋白水平增加。Nox2-Tg主动脉中的p22phox mRNA和蛋白水平也显著升高。与野生型相比,Nox2-Tg小鼠的主动脉超氧化物生成显著增加,但这种差异在内皮去除后消失。超氧化物歧化酶抑制增加了超氧化物释放,与野生型相比,Nox2-Tg小鼠主动脉中锰超氧化物歧化酶蛋白水平显著升高。内皮Nox2过表达导致的ROS生成增加导致转基因主动脉中内皮型一氧化氮合酶蛋白和细胞外信号调节激酶1/2磷酸化增加。基础血压相似,然而与野生型相比,Nox2-Tg小鼠对急性和慢性血管紧张素II给药的升压反应显著增加。这些结果表明,尽管血管抗氧化酶有代偿性增加,但内皮靶向的Nox2过表达足以增加血管NADPH氧化酶活性,激活下游信号通路,并增强对血管紧张素II的血流动力学反应。含内皮细胞Nox2的NADPH氧化酶在血管氧化还原信号传导中起重要的功能作用。